#Melanoma
Total 2 articles
TechEN
Moderna Merck mRNA Cancer Vaccine Results: 50 Percent Risk Reduction
Moderna and Merck's mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 50% in a 5-year study. Read the latest Phase 2 trial insights.
·
DH
Doyun Han
EN
Tanning bed health risks 2025: The hidden price of a synthetic glow
Explore the tanning bed health risks 2025. Learn why UV beds are classified as Group 1 carcinogens and how they increase melanoma risk by 75%.
·
MC
Minho Choi